Emerging technologies in target identification, drug discovery, molecular markers, and imaging are rapidly changing the face of cancer. This book provides a foundation of knowledge in targeted cancer therapeutics. The treatment of cancer is increasingly being individualized, based on an understanding of underlying biologic mechanisms. Poised to change the landscape in oncology, this volume provides a state-of-the-art overview. It will be valuable to practicing and academic physicians, fellows, residents and students, as well as basic scientists, interested in the cancer field.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
Emerging technologies in target identification, drug discovery, molecular markers, and imaging are rapidly changing the face of cancer. This book provides a foundation of knowledge in targeted cancer therapeutics. The treatment of cancer is increasingly being individualized, based on an understanding of underlying biologic mechanisms. Poised to change the landscape in oncology, this volume provides a state-of-the-art overview. It will be valuable to practicing and academic physicians, fellows, residents and students, as well as basic scientists, interested in the cancer field.
Imprint | HumanaPress |
Country of origin | United States |
Series | Current Clinical Oncology |
Release date | April 2008 |
Availability | Expected to ship within 10 - 15 working days |
First published | 2008 |
Editors | Razelle Kurzrock, Maurie Markman |
Dimensions | 254 x 178 x 30mm (L x W x T) |
Format | Hardcover |
Pages | 446 |
Edition | 2008 ed. |
ISBN-13 | 978-1-60327-423-4 |
Barcode | 9781603274234 |
Categories | |
LSN | 1-60327-423-5 |